The most promising candidates for OSA diagnosis were identified by the mRNA levels of ADAM29, FLRT2, and SLC18A3 in PBMCs, Endocan, and YKL-40 in serum, and IL-6, and Vimentin in plasma. Here, FLRT2 is linked to obstructive sleep apnea syndrome.